Intra-cellular therapies to host fourth quarter and full year 2023 financial results conference call and webcast

New york, feb. 08, 2024 (globe newswire) -- intra-cellular therapies, inc. (nasdaq: itci), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (cns) disorders, today announced it will host a conference call and live webcast discussion at 8:30 a.m. eastern time on thursday, february 22, 2024, to provide a corporate update and discuss details of the company's financial results for the quarter and year ended december 31, 2023.
ITCI Ratings Summary
ITCI Quant Ranking